These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 9693387)

  • 21. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J; Peroutka SJ
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonergic modulation of zebrafish behavior: towards a paradox.
    Herculano AM; Maximino C
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Dec; 55():50-66. PubMed ID: 24681196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant treatment can normalize adult behavioral deficits induced by early-life exposure to methylphenidate.
    Bolaños CA; Willey MD; Maffeo ML; Powers KD; Kinka DW; Grausam KB; Henderson RP
    Biol Psychiatry; 2008 Feb; 63(3):309-16. PubMed ID: 17884021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test.
    Page ME; Detke MJ; Dalvi A; Kirby LG; Lucki I
    Psychopharmacology (Berl); 1999 Nov; 147(2):162-7. PubMed ID: 10591883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The medical benefit of 5-HT research.
    Jones BJ; Blackburn TP
    Pharmacol Biochem Behav; 2002 Apr; 71(4):555-68. PubMed ID: 11888547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses?
    Montgomery SA; Fineberg N
    Br J Psychiatry Suppl; 1989 Dec; (8):63-9. PubMed ID: 2692641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonergic mechanisms in psychiatric disorders: new research tools, new ideas.
    Benkelfat C
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():53-6. PubMed ID: 8201247
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of serotonergic agents in the clinical assessment of central serotonin function.
    Murphy DL; Mueller EA; Garrick NA; Aulakh CS
    J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological basis of depression and therapeutic relevance.
    Richelson E
    J Clin Psychiatry; 1991 Jun; 52 Suppl():4-10. PubMed ID: 1646793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute tryptophan depletion: a method of studying antidepressant action.
    Miller HL; Delgado PL; Salomon RM; Licinio J; Barr LC; Charney DS
    J Clin Psychiatry; 1992 Oct; 53 Suppl():28-35. PubMed ID: 1429482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior.
    Popova NK; Naumenko VS; Cybko AS; Bazovkina DV
    Neuroscience; 2010 Aug; 169(1):229-35. PubMed ID: 20423722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The WAG/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression [corrected].
    Sarkisova K; van Luijtelaar G
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):854-76. PubMed ID: 21093520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xiaochaihutang attenuates depressive/anxiety-like behaviors of social isolation-reared mice by regulating monoaminergic system, neurogenesis and BDNF expression.
    Ma J; Wang F; Yang J; Dong Y; Su G; Zhang K; Pan X; Ma P; Zhou T; Wu C
    J Ethnopharmacol; 2017 Aug; 208():94-104. PubMed ID: 28687505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2016 Jul; 54(7):21-4. PubMed ID: 27362381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible clinical applications of serenics and some implications of their preclinical profile for their clinical use in psychiatric disorders.
    Rasmussen DL; Olivier B; Raghoebar M; Mos J
    Drug Metabol Drug Interact; 1990; 8(1-2):159-86. PubMed ID: 2091889
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypothalamic serotonin in treatments for feeding disorders and depression as studied by brain microdialysis.
    Hernandez L; Parada M; Baptista T; Schwartz D; West HL; Mark GP; Hoebel BG
    J Clin Psychiatry; 1991 Dec; 52 Suppl():32-40. PubMed ID: 1752857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Social cognition.
    Patin A; Hurlemann R
    Handb Exp Pharmacol; 2015; 228():271-303. PubMed ID: 25977087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.